DNM1L and Huntington disease: Treatment with peptide inhibitor DA1 that blocks Drp1/ATAD3A interaction can rescue mitochondrial fragmentation and mtDNA lesion, and HD-related pathologies in HD mouse models (Zhao Y. et al., 2019).